BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7067621)

  • 1. Cefoxitin therapy in aerobic, anaerobic, and mixed aerobic-anaerobic infections.
    LeFrock JL; Schell RF; Carr BB; Kowalsky SF; Tillotson JR
    Drug Intell Clin Pharm; 1982 Apr; 16(4):306-12. PubMed ID: 7067621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoxitin: clinical evaluation in thirty-eight patients.
    Heseltine PN; Busch DF; Meyer RD; Finegold SM
    Antimicrob Agents Chemother; 1977 Mar; 11(3):427-34. PubMed ID: 855997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.
    Sweet RL; Ledger WJ
    Obstet Gynecol; 1979 Aug; 54(2):193-8. PubMed ID: 460753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoxitin for treatment of infections due to anaerobic bacteria.
    Kirby BD; Busch DF; Citron DM; Finegold SM
    Rev Infect Dis; 1979; 1(1):113-7. PubMed ID: 318212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoxitin: an overview of clinical studies in the United States.
    Neu HC
    Rev Infect Dis; 1979; 1(1):233-9. PubMed ID: 400937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoxitin sodium therapy of anaerobic infections.
    Busch DF; Heseltine PN; Meyer RD; Sutter VL; Finegold SM
    J Antimicrob Chemother; 1978 Jul; 4(B):197-202. PubMed ID: 357386
    [No Abstract]   [Full Text] [Related]  

  • 8. Cefoxitin therapy of anaerobic and aerobic infections.
    Tally FP; Miao PV; O'Keefe JP; Gorbach SL
    J Antimicrob Chemother; 1979 Jan; 5(1):101-8. PubMed ID: 761998
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacteriological and clinical evaluation of cefoxitin in the treatment of infections in 39 obstetric and gynecological patients].
    Kaseki S; Mano T; Tomoda Y; Kazato S; Asai Y; Sahara K; Manba S; Maruyama T; Kasugai M; Higashide K; Sekiya H; Mizutani S; Watanabe K; Ueno K
    Jpn J Antibiot; 1983 Mar; 36(3):509-21. PubMed ID: 6876361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with cefoxitin sodium.
    Shah PM; Helm EB; Stille W
    J Antimicrob Chemother; 1978 Jul; 4(B):117-25. PubMed ID: 357376
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefoxitin in the treatment of aerobic and anaerobic infections. Prospective correlation of in vitro susceptibility methods with clinical outcome.
    Goldstein EJ; Citron DM; Cole RE; Rangel DM; Seid AS; Ostovari MO
    Hosp Pract (Off Ed); 1990 Oct; 25 Suppl 4():38-45. PubMed ID: 2120272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cefoxitin, new cephalosporin-like antibiotic, in the treatment of aerobic and anaerobic infections.
    Nair SR; Cherubin CE
    Antimicrob Agents Chemother; 1978 Dec; 14(6):866-75. PubMed ID: 742874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections.
    Sweet RL; Robbie MO; Ohm-Smith M; Hadley WK
    Am J Obstet Gynecol; 1983 Feb; 145(3):342-9. PubMed ID: 6218755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.
    McCloskey RV
    Antimicrob Agents Chemother; 1977 Nov; 12(5):636-41. PubMed ID: 335968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular cefoxitin.
    McCloskey RV
    Rev Infect Dis; 1979; 1(1):224-7. PubMed ID: 400934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoxitin sodium treatment of anaerobic and polymicrobial aerobic infections.
    McCloskey RV
    J Antimicrob Chemother; 1978 Jul; 4(B):223-5. PubMed ID: 357392
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of mezlocillin.
    Thadepalli H; Rao B
    Antimicrob Agents Chemother; 1979 Nov; 16(5):605-10. PubMed ID: 526001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of cefoxitin in the treatment of respiratory tract and other acute bacterial infections.
    Weinstein MP; Eickhoff TC
    Rev Infect Dis; 1979; 1(1):158-64. PubMed ID: 318217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteriological and clinical studies of cefoxitin with special reference to anaerobic infections in the patients of abdominal surgery (author's transl)].
    Karaki K; Katada M; Kawaguchi H; Sasaki K; Kobayashi H; Inoue I; Kawai F; Uehara K; Sasaki H; Uegaki K; Deguchi K
    Jpn J Antibiot; 1981 Sep; 34(9):1320-34. PubMed ID: 7328755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.